Clinical Evaluation of Shallaki and its comparative synergistic effect with Lepa and Janu Vasti in Janusandhigata Vata with special reference to Knee Joint Osteoarthritis

ational Institute of Ayurvea0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patients in the age group of 40 to 70 years of either sex.
•2.Patients having signs and symptoms of Janusandhigata Vata of Shotha (edema), Vatapurnadriti Sparsha (on palpation revealed as air filled bag) and pain with Prasaran (extension) and Akunchan (flexion) movements.
•3.Patients having chronicity of disease Janusandhigata Vata (KOA) for less than 5 years.
•4.Patients willing to sign consent form for the clinical trial.
•5.Kellgren Lawrence (Radiological scale) of eâ?? >=2

•1.Patients below 40 years and above 70 years of age.
•2.Patients of Rheumatoid arthritis, Ankylosing and traumatic arthritis.
•3.Patients suffering from paralysis, muscular dystrophy, polio affected persons or persons
•with bony deformities
•4.Patients having systemic conditions such as Tuberculosis, Brucellosis, Osteomyelitis,
•Gouty Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus
•5.Patients having neoplasm of spine and other complicated diseases like CCF, DM,
•Uncontrolled HTN, Unstable Angina, Recent MI etc.
•6.Patients using anti-inflammatory medicines including Allopathic medicine and
•AYUSH medicines.

发起方

ational Institute of Ayurvea